{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T15:15:00Z","timestamp":1790349300461,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005283","name":"Funda\u00e7\u00e3o Cearense de Apoio ao Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005283","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.pnpbp.2024.111089","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T07:25:16Z","timestamp":1720941916000},"page":"111089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Effectiveness of pharmacological interventions for managing ADHD symptoms in individuals with autism spectrum disorder: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"134","author":[{"given":"Paulo Levi Bezerra","family":"Martins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo C\u00e9sar Parente","family":"Torquato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Alberto Pinheiro Fernandes","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel Bessa","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thays Macedo","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel Porf\u00edrio","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle S.","family":"Macedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2024.111089_bb0005","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"issue":"10","key":"10.1016\/j.pnpbp.2024.111089_bb0010","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1097\/01.chi.0000231976.28719.2a","article-title":"Atomoxetine for hyperactivity in autism Spectrum disorders: placebo-controlled crossover pilot trial","volume":"45","author":"Arnold","year":"2006","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0015","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","article-title":"Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study","volume":"380","author":"Barnett","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0020","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S003329171400172X","article-title":"The epidemiology and global burden of autism spectrum disorders","volume":"45","author":"Baxter","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0025","series-title":"Comprehensive Meta-Analysis Version 4","author":"Borenstein","year":"2022"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/aur.1449","article-title":"Overlap between autism Spectrum disorders and attention deficit hyperactivity disorder: searching for distinctive\/common clinical features","volume":"8","author":"Craig","year":"2015","journal-title":"Autism Res."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s13311-012-0126-9","article-title":"Treatment for co-occurring attention deficit\/hyperactivity disorder and autism Spectrum disorder","volume":"9","author":"Davis","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0040","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0040-1701658","article-title":"ADHD: current concepts and treatments in children and adolescents","volume":"51","author":"Drechsler","year":"2020","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0045","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2215-0366(16)00096-1","article-title":"Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms","volume":"3","author":"Gallo","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0050","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.3390\/ijms21134726","article-title":"Clinical assessment, genetics, and treatment approaches in autism Spectrum disorder (ASD)","volume":"21","author":"Genovese","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.pnpbp.2024.111089_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/cap.2008.0137","article-title":"Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit\/hyperactivity disorder symptoms in preschoolers with developmental disorders","volume":"19","author":"Ghuman","year":"2009","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0060","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature13394","article-title":"Genome sequencing identifies major causes of severe intellectual disability","volume":"511","author":"Gilissen","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pnpbp.2024.111089_bb0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1023\/A:1005548619694","article-title":"Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder","volume":"30","author":"Handen","year":"2000","journal-title":"J. Autism Dev. Disord."},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111089_bb0070","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jaac.2015.08.013","article-title":"Atomoxetine, parent training, and their combination in children with autism Spectrum disorder and attention-deficit\/hyperactivity disorder","volume":"54","author":"Handen","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"7","key":"10.1016\/j.pnpbp.2024.111089_bb0075","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.jaac.2012.04.011","article-title":"A randomized double-blind study of atomoxetine versus placebo for attention-deficit\/hyperactivity disorder symptoms in children with autism Spectrum disorder","volume":"51","author":"Harfterkamp","year":"2012","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111089_bb0080","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/cap.2014.0026","article-title":"Atomoxetine in autism Spectrum disorder: no effects on social functioning; some beneficial effects on stereotyped behaviors, inappropriate speech, and fear of change","volume":"24","author":"Harfterkamp","year":"2014","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2024.111089_bb0085","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/cap.2015.0130","article-title":"Caregiver satisfaction with a multisite trial of atomoxetine and parent training for attention-deficit\/hyperactivity disorder and behavioral noncompliance in children with autism Spectrum disorder","volume":"26","author":"Hollway","year":"2016","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0090","doi-asserted-by":"crossref","unstructured":"Hollway, Jill A. et al., 2018. Atomoxetine, parent training, and their effects on sleep in youth with autism Spectrum disorder and attention-deficit\/hyperactivity disorder. J. Child Adolesc. Psychopharmacol., [S. L.], V. 28, N. 2, P. 130\u2013135.","DOI":"10.1089\/cap.2017.0085"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0095","doi-asserted-by":"crossref","unstructured":"Jahromi, Laudan B. et al. Positive Effects Of Methylphenidate On Social Communication And Self-Regulation In Children With Pervasive Developmental Disorders And Hyperactivity. J. Autism Dev. Disord., [S. L.], V. 39, N. 3, P. 395\u2013404, 2009.","DOI":"10.1007\/s10803-008-0636-9"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0100","doi-asserted-by":"crossref","unstructured":"Jaselskis, C. A. et al. Clonidine Treatment Of Hyperactive And Impulsive Children With Autistic Disorder. J. Clin. Psychopharmacol., [S. L.], V. 12, N. 5, P. 322\u2013327, 1992.","DOI":"10.1097\/00004714-199210000-00005"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0105","doi-asserted-by":"crossref","unstructured":"Lecavalier, Luc et al., 2018. Parent stress in a randomized clinical trial of atomoxetine and parent training for children with autism Spectrum disorder. J. Autism Dev. Disord., [S. L.], V. 48, N. 4, P. 980\u2013987.","DOI":"10.1007\/s10803-017-3345-4"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fnhum.2014.00268","article-title":"The co-occurrence of autism and attention deficit hyperactivity disorder in children \u00e2\u20ac what do we know?","volume":"8","author":"Leitner","year":"2014","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0115","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0140-6736(18)31129-2","article-title":"Autism spectrum disorder","volume":"392","author":"Lord","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0120","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.25825","article-title":"A delayed diagnosis of autism Spectrum disorder in the setting of complex attention deficit hyperactivity disorder","author":"Malwane","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0125","doi-asserted-by":"crossref","first-page":"65","DOI":"10.31887\/DCNS.2020.22.1\/macrocq","article-title":"Neurodevelopmental disorders\u2014the history and future of a diagnostic concept","volume":"22","author":"Morris-Rosendahl","year":"2020","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0130","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10803-008-0621-3","article-title":"Autism symptoms in attention-deficit\/hyperactivity disorder: a familial trait which correlates with conduct, oppositional defiant, language and motor disorders","volume":"39","author":"Mulligan","year":"2009","journal-title":"J. Autism Dev. Disord."},{"issue":"71","key":"10.1016\/j.pnpbp.2024.111089_bb0135","article-title":"The Prisma 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"160","key":"10.1016\/j.pnpbp.2024.111089_bb0140","article-title":"Prisma 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0145","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","article-title":"Neurodevelopmental disorders: from genetics to functional pathways","volume":"43","author":"Parenti","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0150","doi-asserted-by":"crossref","unstructured":"Pearson, Deborah A. et al. 2013. Effects of extended release methylphenidate treatment on ratings of attention-deficit\/hyperactivity disorder (Adhd) and associated behavior in children with autism Spectrum disorders and Adhd symptoms. J. Child Adolesc. Psychopharmacol., [S. L.], V. 23, N. 5, P. 337\u2013351.","DOI":"10.1089\/cap.2012.0096"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0155","doi-asserted-by":"crossref","unstructured":"Politte, Laura C. et al., 2018. A Randomized, Placebo-Controlled Trial Of Extended-Release Guanfacine In Children With Autism Spectrum Disorder And Adhd Symptoms: An Analysis Of Secondary Outcome Measures. Neuropsychopharmacology: Official Publication Of The American College Of Neuropsychopharmacology, [S. L.], V. 43, N. 8, P. 1772\u20131778.","DOI":"10.1038\/s41386-018-0039-3"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0160","doi-asserted-by":"crossref","unstructured":"Posey, David J. et al. Positive Effects Of Methylphenidate On Inattention And Hyperactivity In Pervasive Developmental Disorders: An Analysis Of Secondary Measures. Biol. Psychiatry, [S. L.], V. 61, N. 4, P. 538\u2013544, 2007.","DOI":"10.1016\/j.biopsych.2006.09.028"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0165","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(19)33004-1","article-title":"Attention-deficit hyperactivity disorder","volume":"395","author":"Posner","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0170","doi-asserted-by":"crossref","unstructured":"Quintana, H. Et Al., 1995. Use Of Methylphenidate In The Treatment Of Children With Autistic Disorder. J. Autism Dev. Disord., [S. L.], V. 25, N. 3, P. 283\u2013294, 1995.","DOI":"10.1007\/BF02179289"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0180","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s10802-009-9312-6","article-title":"Comorbid problems in ADHD: degree of association, shared Endophenotypes, and formation of distinct subtypes. Implications for a future DSM","volume":"37","author":"Rommelse","year":"2009","journal-title":"J. Abnorm. Child Psychol."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0185","doi-asserted-by":"crossref","unstructured":"Scahill, Lawrence et al., 2015. Extended-release Guanfacine for hyperactivity in children with autism Spectrum disorder. Am. J. Psychiatry, [S. L.], V. 172, N. 12, P. 1197\u20131206.","DOI":"10.1176\/appi.ajp.2015.15010055"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0190","doi-asserted-by":"crossref","unstructured":"Scahill, Lawrence et al., 2017. Using a patient-centered outcome measure to test methylphenidate versus placebo in children with autism Spectrum disorder. J. Child Adolesc. Psychopharmacol., [S. L.], V. 27, N. 2, P. 125\u2013131.","DOI":"10.1089\/cap.2016.0107"},{"issue":"11","key":"10.1016\/j.pnpbp.2024.111089_bib227","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1001\/archpsyc.62.11.1266","article-title":"Research Units on Pediatric Psychopharmacology Autism Network (RUPP study). Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity","volume":"62","year":"2005","journal-title":"Arch. Gen. Psychiatry."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0195","first-page":"1475","article-title":"How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis. CMAJ can","volume":"165","author":"Schachter","year":"2001","journal-title":"Med. Assoc. J. J. Assoc. Medicale Can."},{"key":"10.1016\/j.pnpbp.2024.111089_bb0200","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1542\/peds.2012-0900G","article-title":"Attention-deficit\/hyperactivity disorder symptoms, adaptive functioning, and quality of life in children with autism Spectrum disorder","volume":"130","author":"Sikora","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0205","doi-asserted-by":"crossref","unstructured":"Smith, Tristram et al., 2016. Atomoxetine and parent training for children with autism and attention-deficit\/hyperactivity disorder: a 24-week extension study. J. Am. Acad. Child Adolesc. Psychiatry, [S. L.], V. 55, N. 10, P. 868\u2013876.E2.","DOI":"10.1016\/j.jaac.2016.06.015"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0210","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"l4898","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0215","first-page":"339","article-title":"Neurodevelopmental disorders. Lancet","volume":"4","author":"Thapar","year":"2017","journal-title":"Psychiatry"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0220","doi-asserted-by":"crossref","unstructured":"Tumuluru, Rameshwari V. Et Al., 2017 Adverse events of atomoxetine in a double-blind placebo-controlled study in children with autism. J. Child Adolesc. Psychopharmacol., [S. L.], V. 27, N. 8, P. 708\u2013714.","DOI":"10.1089\/cap.2016.0187"},{"key":"10.1016\/j.pnpbp.2024.111089_bb0225","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/ijms24031819","article-title":"Autism Spectrum disorder: neurodevelopmental risk factors, biological mechanism, and precision therapy","volume":"24","author":"Wang","year":"2023","journal-title":"Int. J. Mol. Sci."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462400157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027858462400157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T06:22:57Z","timestamp":1728454977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027858462400157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":45,"alternative-id":["S027858462400157X"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111089","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of pharmacological interventions for managing ADHD symptoms in individuals with autism spectrum disorder: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2024.111089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111089"}}